LIFE SCIENCE For EBP & MED TECH PATIENT PROFILING

Higher quality patients. More opportunity.

IQVIA’s patient profiling is purpose-built to develop clear insights by enabling you to cost-effectively:

  • Make greater sense of the growing mountains of patient data available
  • Gain insights into therapeutic effectiveness
  • Expand your diagnosed cohort and identify undiagnosed patients accurately
  • Gain transformational patient and product efficacy insights
  • Innovatively engage with your customers

Are you ready to elevate your ability to precisely identify the right patients?

CLINICAL FEASIBILITY

Streamline and improve clinical feasibility assessments

It’s Your Choice: Rapid Self-Managed or Fully Managed Data Feasibility Assessments.

Leverage IQVIA’s Fully Managed services to run a feasibility study on your treatment/drug of choice across both internal and IQVIA data assets, using global, OMOPed data. Analyze multiple variables such as drug usage, condition occurrence, procedures, lab tests, visits, providers.

Or harness our powerful self-managed data analysis tools to quickly determine study data appropriateness with unlimited feasibility requests, instant descriptive analytic summaries, and enterprise-wide library of re-useable feasibility codelists and queries.

 

CLINICAL FEASIBILITY

Quickly assess whether a study is viable via our extensive data network and powerful tools

Vast data network of 2 billion+ records

Supporting native and standardized common data models (OMOP), our global network gives you access to more than 450 databases across 80 countries (and growing) including more than 2 billion patient records. most of which are otherwise unavailable.

Get insights in all key areas of understanding

Cost-effectively accelerate speed-to-insight. Get faster answers to questions about: Drug utilization, Drug safety, Health economics, Trial design, Trial feasibility, Treatment Pathways and comparative effectiveness.

Answer crucial feasibility questions faster

Quickly assess whether a study is practical and achievable given available resources, data, and design. Re-use previous definitions, gold-standard code lists, build a library of repeatable feasibility questions, and be able to visualize the answers.

Unlimited self-managed option gives more insight, for less

Analyse product viability, identify challenges and optimize analysis strategies. Our self-service tools let you ask unlimited self-serve feasibility questions across multiple datasets and get rapid answers at low cost.

COHORT CHARACTERIZATION

Global multi-database analysis made easy

IQVIA solutions for standardized analysis of real world data that support detailed analytics in areas such as drug efficacy, comparative drug performance, and cost effectiveness.

  • Our fully-managed service saves time and cost by providing comprehensive analysis via a federated data network model with OMOP formatted data (OHDSI, EHDEN), allowing potential global data access to commercially unavailable data.
  • The self-managed software solution enables researchers to easily build complex criteria, analyze patient data, and share insights through dashboards and reports.

Either option lets you analyze and identify and health trends and patterns across entire populations to accelerate insights and support informed decisions.

Contact us to speak to a helpful IQVIA expert.

 

COHORT CHARACTERIZATION

Standardization for seamless multi-database analysis

Access commercially unavailable global data

The federated network model enables centralized planning and remote execution of analyses, saving time and costs while providing potential access to commercially unavailable data.

Gain efficiency, save on costs

Our cost-effective self-managed solution rapidly provisions data and offers sophisticated analysis tools. Established feasibility methodologies and a reusable library of cohort characterization analyses and reports enhance efficiency.

Reliability & reproducibility

The OMOP Common Data Model harmonizes diverse data formats and content, allowing easy cross-country analysis. Standardization eliminates the need to develop queries and studies multiple times, improving efficiency.

Reduce cost of ownership

Conduct unlimited studies across datasets with our self-managed solution for rapid answers, fast output & easy distribution at low cost.

Our fully-managed solution reduces cost of ownership and eliminates administrative barriers by executing remote analysis without accessing patient-level data, ensuring data governance and privacy compliance.

HEALTH DATA ACCESS

Rapidly access, identify and transform large scale global health data

Augment your analytical pipelines and streamline your data access requirements with simple-to-use tools and industry leading export technologies.

Gain robust, and simple access to health data across your organization to transform the way teams analyze and generate insights across different workflows.

 

HEALTH DATA ACCESS

Augment your analytical pipelines and streamline your data access

Get access to only the data you need, when you need it

Improves access to multiple data sources to speed up time to insights.

Seamlessly integrate your workflows

Perform feature engineering and deliver direct to your analytical workflows with multiple data delivery options (Snowflake, AWS S3, etc.).

Eliminates barriers

Remove barriers to collaboration and improve access to multiple IQVIA global health data assets.

Improve workflow efficiency

promote collaboration and empower your different teams with centralized access to even the largest IQVIA data sources.

MARKET SIZING AND OPPORTUNITY MODELING

Identify the full market size & high-opportunity patients

Understand the addressable population and physicians likely to adopt your product with high accuracy so you can optimize marketing and sales resources, improve competitiveness, and reach maximum market opportunity.

Accelerate product performance by understanding the addressable population for a disease and the physicians likely to adopt your product with high accuracy. With IQVIA's analytic solutions, you can leverage AI-powered methodologies and build out accurate patient populations using comprehensive real world data and multiple criteria. Stay ahead of the competition and achieve breakthrough advancements in healthcare with IQVIA.

 

MARKET OPPORTUNITY MODELING

Discover high-opportunity patients

Find up to 95x more undiagnosed patients

IQVIA predictive modelling identified 95x more undiagnosed patients for ultra-rare diseases than a rules-based approach.

Up to 39X conversion rate

IQVIA predictive models have a 16X conversion rate compared to control patients, increasing to 39X for high-risk patients.

500% greater rate of transition

Patients predicted by IQVIA predictive models had a 500% greater rate of transition to client’s treatment than the previous rules-based approach.

86% accuracy using ML

IQVIA predictive models accurately predicted 86% of uncontrolled asthma patients with 30% greater precision than a rules-based approach.

PATIENT CHARACTERIZATION & JOURNEY

Explore market changes to find new intervention points

IQVIA Patient Characterization and Journey delivers highly diverse patient profiles, complex journey mapping, and related HCP interactions with speed and precision.

Using Patient Characterization and Journey, you can access constantly updated analytics to understand competitive share, diagnosing pathways, eligibility, and prescribing patterns to find new intervention points and physicians to target.

With our cost-efficient and consultative support, you can streamline your efforts to be more agile, competitive, and focused on market share growth.

 

PATIENT CHARACTERIZATION & JOURNEY

Precise Patient Profiling and Journey Mapping for Enhanced HCP Interactions

Dynamic Characterization & Journey Mapping

Access updated analytics for competitive share, diagnosing pathways, eligibility, and prescribing patterns. Explore market changes pre, during, and post-launch for new intervention points and targeted physician outreach.

Largest patient and HCP databases available

Leverage the largest and most robust global databases available, refreshed weekly to maintain currency. IQVIA data covers over 300 million US patients, 92% of retail prescriptions, and 70% of HCPs.

Customer-proven to deliver results

Patients can be found via traditional statistical methods across IQVIA’s patient level prescription, diagnosis, lab, and payer data, or via state-of-the-art machine learning methodologies.

Unrivalled experience and expertise

IQVIA is uniquely positioned to combine our deep domain expertise with a highly consultative approach. Our capabilities are differentiated by our investment in integrating real world data, transformative technologies, predictive analytics, and healthcare expertise.

Solutions for Payers, Providers & Government

Contact Us